Sonnet BioTherapeutics Holdings, Inc.
New Filing
CIK: 0001106838·Biotechnology·DELAWARE·Filed: Aug 19, 2022
Total Offering
$2,250,000
Amount Sold
$2,250,000
Investors
5
First Sale
Aug 15, 2022
Offering Details
- Type
- Equity, Option to Acquire, Security to be Acquired
- Exemptions
- Rule 506(b)
- Entity Type
- Corporation
- Non-Accredited Investors
- No
Related Persons
| Name | Role |
|---|---|
| Pankaj Mohan | Related Person |
| Jay Cross | Related Person |
| John K. Cini | Related Person |
| Susan Dexter | Related Person |
| Richard Kenny | Related Person |
| Nailesh Bhatt | Related Person |
| Albert Dyrness | Related Person |
| Donald Griffith | Related Person |
| Raghu Rao | Related Person |
Company
SEC Filing
0001493152-22-023618
View on SEC EDGARWant deeper insights?
Sign up for free to search all filings, track companies, and set up alerts.
Sign Up Free